---
title: "Rituximab (MabThera(r)) 1400mg/11.7ml Subcutaneous Injection"
ocid: "ocds-r6ebe6-0000503626"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000503626"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000503626.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000503626.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"NSS\")"
published: "2017-07-31"
---

# Rituximab (MabThera(r)) 1400mg/11.7ml Subcutaneous Injection

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")  
Current stage: Award  
OCID: ocds-r6ebe6-0000503626

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000503626)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000503626.json)

## Summary

The Common Services Agency, also known as NHS National Services Scotland (NSS), is conducting a public procurement process for the supply of Rituximab (MabThera) 1400mg/11.7ml subcutaneous injection. This tender falls under the health industry category and is located in Edinburgh, UK. The procurement is currently at the award stage, with contracts signed on 24th July 2017, following a limited procurement method without prior publication of a call for competition due to patent protection for the medicine. The framework agreement covers a duration of 23 months, with an option for a 12-month extension.

This tender presents significant opportunities for pharmaceutical companies, particularly those specialised in biologic drugs and who can supply patented medications. Businesses experienced in navigating NHS procurement processes and those able to meet the stringent requirements for healthcare products will be well-suited to compete for this contract. The potential for sustained engagement with NHS Scotland through this framework agreement could lead to further opportunities for expansion and revenue growth within the public health sector.

## Notice

The supply of rituximab (MabThera) 1400mg/11.7ml subcutaneous injection to NHS Scotland.

### Lot Information

Lot 1

The supply of rituximab (MabThera(r)) 1400mg/11.7ml subcutaneous injection to NHS Scotland.

### Procurement Information

The medicine awarded to this framework agreement is, and will remain to be, protected by patent for the duration of the framework agreement.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG291317 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Not specified |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 31 Jul 2017 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 24 Jul 2017 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS") |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33690000 - Various medicinal products

## Release History

- 31 Jul 2017 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG291317
- 10 Jul 2017 at 00:00 - Award - OJEU - F15 - Voluntary Ex Ante Transparency Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL289288

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL289288
  Rituximab (MabThera) Subcutaneous 1400mg/11.7ml Vials - The supply of rituximab (MabThera) Subcutaneous 1400mg/11.7ml Vials to NHS Scotland.
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG291317
  Rituximab (MabThera(r)) 1400mg/11.7ml Subcutaneous Injection - The supply of rituximab (MabThera) 1400mg/11.7ml subcutaneous injection to NHS Scotland.

## Notice URLs

- http://
- http://www.nhsscotlandprocurement.scot.nhs.uk/
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000503626

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000503626. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000503626.json.